DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Tay-Sachs Disease - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tay-Sachs Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Temporomandibular Disorders - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Temporomandibular Disorders - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...
January 2022
60 pages
Tendinopathy - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tendinopathy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Tendonitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tendonitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
tenosynovitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'tenosynovitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
Teriparatide– Biosimilar Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Teriparatide– Biosimilar 2022,” report provides comprehensive insights about 10+ companies and 10+ marketed and pipeline...
January 2022
60 pages
Throat Cancer - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Throat Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
Thymic carcinoma - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Thymic carcinoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...
January 2022
60 pages
Thymidylate synthase inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Thymidylate synthase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 18+ compa...
January 2022
60 pages
Thyroid Eye Disease (TED) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Thyroid Eye Disease (TED) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Thyroid hormone receptor agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Thyroid Hormone Receptor Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies an...
January 2022
60 pages
Tick Borne Encephalitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tick Borne Encephalitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
TIE-2 receptor agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “TIE-2 receptor agonists - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and...
January 2022
60 pages
TIGIT inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “TIGIT inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 14+ companies and 18+ pi...
January 2022
60 pages
TIL therapy - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “TIL Therapy - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs i...
January 2022
120 pages
Tinea Pedis - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tinea Pedis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Tinnitus - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tinnitus - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical an...
January 2022
60 pages
Tonic clonic Seizure - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Tonic clonic Seizure - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
TRAIL receptor 2 agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “TRAIL receptor 2 agonists - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies an...
January 2022
60 pages
